EQUILLIUM, INC. (EQ) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2023-03-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2023-03-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2023-03-31..
Borrowing debt
Overview →Financial period ending 2023-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2023-03-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2023-03-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2023-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 5.71M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 1.84M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | 61.99M USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 71.79M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | (m) | (m) | $5.71M | $1.84M | (m) | $61.99M | $71.79M | (m) |
| 2022-12-31 | (m) | (m) | $5.71M | $3.24M | (m) | $71.02M | $78.42M | (m) |
| 2022-09-30 | (m) | (m) | $5.71M | $4.62M | (m) | $44.52M | $48.63M | (m) |
| 2022-06-30 | (m) | (m) | $4.29M | $5.99M | (m) | $57.56M | $62.47M | (m) |
| 2022-03-31 | (m) | (m) | $2.86M | $7.37M | (m) | $68.82M | $74.23M | (m) |
| 2021-12-31 | (m) | (m) | $1.43M | $8.75M | (m) | $80.71M | $85.41M | (m) |
| 2021-09-30 | (m) | (m) | $1.25M | $8.87M | (m) | $90.69M | $92.47M | (m) |
| 2021-06-30 | (m) | (m) | $0.00 | $10.07M | (m) | $97.64M | $99.84M | (m) |
| 2021-03-31 | (m) | (m) | $2.50M | $7.51M | (m) | $104.08M | $106.84M | (m) |
| 2020-12-31 | (m) | (m) | $1.67M | $8.28M | (m) | $82.16M | $85.43M | (m) |
| 2020-09-30 | (m) | (m) | $833.00K | $9.04M | (m) | $90.54M | $92.39M | (m) |
| 2020-06-30 | (m) | (m) | (m) | $9.81M | (m) | $42.61M | $44.26M | (m) |
| 2020-03-31 | (m) | (m) | (m) | $9.75M | (m) | $47.67M | $49.91M | (m) |
| 2019-12-31 | (m) | (m) | (m) | $9.68M | (m) | $53.14M | $55.54M | (m) |
| 2019-09-30 | (m) | (m) | (m) | $9.62M | (m) | $62.24M | $62.99M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |